P04-03600: PAN-Biotech DMEM, w: 4.5 g/L Glucose, w/o: L-Glutamine, w: Sodium pyruvate, w: 3.7 g/L NaHCO3, 500 ml bottle
P04-036001: PAN-Biotech DMEM, w: 4.5 g/L Glucose, w/o: L-Glutamine, w: Sodium pyruvate, w: 3.7 g/L NaHCO3, 1 L bottle
  • Load image into Gallery viewer, P04-03600: PAN-Biotech DMEM, w: 4.5 g/L Glucose, w/o: L-Glutamine, w: Sodium pyruvate, w: 3.7 g/L NaHCO3, 500 ml bottle
  • Load image into Gallery viewer, P04-036001: PAN-Biotech DMEM, w: 4.5 g/L Glucose, w/o: L-Glutamine, w: Sodium pyruvate, w: 3.7 g/L NaHCO3, 1 L bottle

PAN-Biotech DMEM, w: 4.5 g/L Glucose, w/o: L-Glutamine, w: Sodium pyruvate, w: 3.7 g/L NaHCO3

P04-03600
Regular price
$40.00
Sale price
$40.00
Regular price
Unavailable
Unit price
per 
Shipping calculated at checkout.

Introduction

Intrinsically developed for the cultivation of murine embryonic cells, DMEM (Dulbecco's Modified Eagle Medium) is tailor-made for the cultivation of a broad range of cells, especially if the medium is supplemented with FBS. DMEM is an Eagle medium modification with a fourfold content of amino acids and vitamins. DMEM with 1.0 g/L Glucose is the standard medium, whereas DMEM with 4.5 g/L Glucose is for cells which have a high energy demand.

Composition

PAN-Biotech DMEM, w: 4.5 g/L Glucose, w/o: L-Glutamine, w: Sodium pyruvate, w: 3.7 g/L NaHCO3

Specifications

Bicarbonate: with Sodium Bicarbonate
Endotoxin Content: Endotoxin Content unspecified
Glucose: High Glucose (4.5 g/L)
Glutamine: No glutamine
HEPES: without HEPES
Liquid / Powder: liquid
Phenol Red: with Phenol Red
Product Category: Cell Culture Media
Product Type: DMEM
Size:

Cat. No. P04-03600X6: 6 x 500 ml

Cat. No. P04-036001X3: 3 x 1000 ml

Sodium Pyruvate: with Sodium Pyruvate
Sterile: Yes
Storage Temperature: +2°C - +8°C

    Documents

    Product References

    • Feles, Sebastian et al. “Streamlining Culture Conditions for the Neuroblastoma Cell Line SH-SY5Y: A Prerequisite for Functional Studies.” Methods and protocols vol. 5,4 58. 12 Jul. 2022, doi:10.3390/mps5040058
    • Dorna, Jens et al. “Effects of Receptor Specificity and Conformational Stability of Influenza A Virus Hemagglutinin on Infection and Activation of Different Cell Types in Human PBMCs.” Frontiers in immunology vol. 13 827760. 14 Mar. 2022, doi:10.3389/fimmu.2022.827760
    • Elazezy, Maha et al. “Emerging Insights into Keratin 16 Expression during Metastatic Progression of Breast Cancer.” Cancers vol. 13,15 3869. 31 Jul. 2021, doi:10.3390/cancers13153869
    • Prentzell, Mirja Tamara et al. “G3BPs tether the TSC complex to lysosomes and suppress mTORC1 signaling.” Cell vol. 184,3 (2021): 655-674.e27. doi:10.1016/j.cell.2020.12.024
    • Kovalchuk, Bogdana et al. “Nintedanib and a bi-specific anti-VEGF/Ang2 nanobody selectively prevent brain metastases of lung adenocarcinoma cells.” Clinical & experimental metastasis vol. 37,6 (2020): 637-648. doi:10.1007/s10585-020-10055-x
    • Boussicault, Lydie et al. “Combination of acamprosate and baclofen (PXT864) as a potential new therapy for amyotrophic lateral sclerosis.” Journal of neuroscience research vol. 98,12 (2020): 2435-2450. doi:10.1002/jnr.24714
    • Bartels, Martin et al. “Iron-mediated aggregation and toxicity in a novel neuronal cell culture model with inducible alpha-synuclein expression.” Scientific reports vol. 9,1 9100. 24 Jun. 2019, doi:10.1038/s41598-019-45298-6
    • Heberle, Alexander Martin et al. “The PI3K and MAPK/p38 pathways control stress granule assembly in a hierarchical manner.” Life science alliance vol. 2,2 e201800257. 28 Mar. 2019, doi:10.26508/lsa.201800257
    • Ruf, Stefanie et al. “PLK1 (polo like kinase 1) inhibits MTOR complex 1 and promotes autophagy.” Autophagy vol. 13,3 (2017): 486-505. doi:10.1080/15548627.2016.1263781
    • Franek, Michal et al. “Nucleolar Reorganization Upon Site-Specific Double-Strand Break Induction.” The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society vol. 64,11 (2016): 669-686. doi:10.1369/0022155416668505

      Ilex Life Sciences LLC is an authorized distributor of PAN-Biotech products.